Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Free Chimeric Scapular with Latissimus Dorsi Myocutaneous Flap as a Third Free Flap for Reconstruction of Metachronous Mandibular Defects-A Rare Case Report.

Created on 04 Aug 2026

Authors

Vineet Kumar, Dharmik Gondalia, Vinay Kant Shankhdhar

Published in

Journal of plastic and reconstructive surgery. Volume 5. Issue 4. Pages 289-295. Jul 27, 2026. Epub Sep 05, 2025.

Abstract

This is a rare case report in which a third free flap was used to restore metachronous mandibular defects. Significant functional and aesthetic losses may result from segmental mandibular excision in cases of oral cancer. The fibula flap is the gold standard for reconstructing these defects, which is essential for regaining shape and function. Reconstruction attempts become more complex when individuals experience metachronous malignancies or recurrence. We present a rare instance in which a third free flap was required for restoration following 2 metachronous mandibular defects. Mandibular continuity was effectively restored using a free chimeric scapular with latissimus dorsi myocutaneous flap, yielding positive functional and cosmetic results. This case report shows that even after prior reconstruction, patients can successfully undergo an additional free flap procedure, improving their quality of life. It further underscores the adaptability and effectiveness of this reconstructive technique in correcting complex mandibular defects.

PMID:
42548952
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement